Ba. Leggett et al., CHARACTERISTICS OF METACHRONOUS COLORECTAL-CARCINOMA OCCURRING DESPITE COLONOSCOPIC SURVEILLANCE, Diseases of the colon & rectum, 40(5), 1997, pp. 603-608
PURPOSE: Metachronous colorectal cancer still occurs in a small percen
tage of patients, despite colonoscopic surveillance. Cancers in heredi
tary nonpolyposis colorectal cancer for which there is a high risk of
metachronous cancer show distinctive DNA changes termed replication er
rors (RER+). Ten to 20 percent of sporadic colorectal cancers are also
RER+. The aim of this study was to identify factors predictive of met
achronous colorectal cancer, despite colonoscopic surveillance. Clinic
opathologic characteristics and RER status of cancers were examined. M
ETHODS: Colorectal tal cancer patients, who entered into a surveillanc
e program of being examined with colonoscopy within six months of surg
ery and then at intervals of three years thereafter, were reviewed. Th
e 433 patients compliant with the protocol who had had more than one c
olonoscopy had been followed up for a mean of 3.8 +/- 2.2 years. DNA w
as extracted from archival paraffin-embedded cancer tissue for determi
nation of RER status. RESULTS: Ten cases of metachronous cancer were i
dentified, giving a rate of 0.61 percent per year. The site of the ind
ex cancer in patients who later developed metachronous cancer was pred
ominantly proximal (P = 0.0007), and these cancers were more likely to
have mucinous histology (P < 0.0005). Three of 10 (30 percent) index
cancers were RER+, which was not significantly different from unselect
ed series of control colorectal cancers in which 20 of 108 (18.5 perce
nt) were RER+. DISCUSSION: This study documents the rate of metachrono
us cancer among patients compliant with a defined colonoscopic screeni
ng program and suggests that the risk is highest in patients with a pr
oximal mucinous cancer. RER status does not appear to be a very strong
predictive factor, and this study does not support its use as a guide
to the frequency of surveillance colonoscopy. More data would be requ
ired to determine if RER positivity conferred a relative risk of 3.3 o
r less.